Ignite Creation Date:
2024-05-06 @ 7:30 PM
Last Modification Date:
2024-10-26 @ 3:08 PM
Study NCT ID:
NCT06038669
Status:
RECRUITING
Last Update Posted:
2024-04-11
First Post:
2023-09-08
Brief Title:
User Evaluation of a Home-collection Kit for People With Diabetes
Sponsor:
University Hospitals of North Midlands NHS Trust
Organization:
University Hospitals of North Midlands NHS Trust
Study Overview
Official Title:
User Evaluation of a Home-collection Kit for People With Diabetes
Status:
RECRUITING
Status Verified Date:
2023-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Type 1 and Type 2 are the most common types of diabetes mellitus Although the cause of Type 1 is different to Type 2 they can both lead to high blood glucose levels as the patient is unable to store and use sugar The disease is an epidemic of the 21st century which is increasing having a current prevalence of approximately 8
Poor disease control is associated with a range of long-term health conditions which have a severe impact upon quality of life and are responsible for the increased morbidity and mortality associated with the disease
Healthcare professionals use HbA1c as the main marker to monitor diabetic control Patients with diabetes have regular review appointments to monitor their overall health and discuss their HbA1c target and results The purpose of monitoring patients with diabetes is to improve patient outcomes It is known that poor control is associated with poor clinical outcomes and also that reduced monitoring is linked to suboptimal diabetic control Therefore aiming for the correct monitoring frequency helps towards achieving the best control which can lead to the most favourable clinical outcomes The inconvenience of attending for a blood test and follow-up appointment is a major factor affecting patient adherence to monitoring locally approximately 50 of patients with diabetes have their HbA1c level measured either too soon or too late
To address this issue and improve access to monitoring at the correct time interval we aim to produce a HbA1c home testing kit which can be posted back to the laboratory at the convenience of the patient The kit will be developed based on feedback from patients with diabetes and will use a dried blood spot sample to produce HbA1c results comparable to the whole blood standard method
Poor disease control is associated with a range of long-term health conditions which have a severe impact upon quality of life and are responsible for the increased morbidity and mortality associated with the disease
Healthcare professionals use HbA1c as the main marker to monitor diabetic control Patients with diabetes have regular review appointments to monitor their overall health and discuss their HbA1c target and results The purpose of monitoring patients with diabetes is to improve patient outcomes It is known that poor control is associated with poor clinical outcomes and also that reduced monitoring is linked to suboptimal diabetic control Therefore aiming for the correct monitoring frequency helps towards achieving the best control which can lead to the most favourable clinical outcomes The inconvenience of attending for a blood test and follow-up appointment is a major factor affecting patient adherence to monitoring locally approximately 50 of patients with diabetes have their HbA1c level measured either too soon or too late
To address this issue and improve access to monitoring at the correct time interval we aim to produce a HbA1c home testing kit which can be posted back to the laboratory at the convenience of the patient The kit will be developed based on feedback from patients with diabetes and will use a dried blood spot sample to produce HbA1c results comparable to the whole blood standard method
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None